Aripiprazole in the treatment of psychiatric disorders in childhood
- 21 November 2025
- journal article
- review article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (10) , 38-47
Abstract
For child psychiatry, the priority task is not only the relief of psychopathological symptoms, but also the preservation and restoration of cognitive functioning. Drugs that are active against a wide range of psychopathological disorders, including the productive, negative, affective, and cognitive domains, while having a favorable tolerance profile, will be the most suitable for solving this problem. The unique therapeutic profile of aripiprazole meets all these requirements. The efficacy and tolerability of Aripiprazole in children and adolescents have been demonstrated in many open-label clinical trials, which served as the basis for the drug’s approval by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, bipolar disorder, and irritability associated with autistic disorder in children and adolescents. Aripiprazole is also included in national clinical guidelines for the treatment of autistic disorders. The high frequency of prescribing aripiprazole in childhood is due not only to its positive effect on negative, cognitive and affective symptoms, but also to its good general tolerance, low probability of developing extrapyramidal symptoms, absence of adverse effects on body weight and metabolic parameters (lipid profile, tissue sensitivity to insulin, etc.).Keywords
This publication has 55 references indexed in Scilit:
- Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical TrialPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2019
- Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled StudyChild Psychiatry & Human Development, 2016
- Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled StudyPediatric Drugs, 2016
- Clinical Effectiveness of Aripiprazole in Short-term Treatment of Tic Disorder in Children and Adolescents: A Naturalistic StudyPediatrics & Neonatology, 2014
- Early Antipsychotic Response to Aripiprazole in Adolescents With Schizophrenia: Predictive Value for Clinical OutcomesJournal of the American Academy of Child & Adolescent Psychiatry, 2013
- Efficacy and safety of aripiprazole in child and adolescent patientsEuropean Child & Adolescent Psychiatry, 2012
- An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar DisorderCNS Spectrums, 2007
- Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorderDepression and Anxiety, 2007
- A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazoleHuman Psychopharmacology: Clinical and Experimental, 2006
- Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychoticEuropean Journal of Pharmacology, 2005